MetaCap

Cadrenal Therapeutics (CVKD) vs Immuron (IMRN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Immuron is the larger company by market cap ($7.3 million vs $7.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CVKD+74.84%IMRN-17.45%
+99%+35%-30%
Oct 7, 20261 yearNov 20, 2026
CVKD+86.79%IMRN-16.69%
+92%+32%-29%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CVKD versus IMRN key metrics
MetricCVKDIMRN
Share price$1.70$0.8998
Market cap$7.01M$7.26M
1-day change+0.59%+5.80%
EPS (TTM)$-3.67$-0.34
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-13.24M—
52-week high$12.50$1.99
52-week low$0.816$0.677
Distance from 52-week high-86.40%-54.78%
Analyst consensusnonenone
Avg. price target upside+723.53%+332.32%
Average volume496.14K2.06M
Shares outstanding4.12M8.07M
Employees57
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Cadrenal Therapeutics

CVKD stock →

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

About Immuron

IMRN stock →

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products.

Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees

CVKD vs IMRN FAQ

Which is bigger, Cadrenal Therapeutics or Immuron?

Immuron (IMRN) is larger, with a market capitalization of $7.26M compared with $7.01M for Cadrenal Therapeutics (CVKD).

Are Cadrenal Therapeutics and Immuron in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons